Shahriar A Nabizadeh Md is categorized under Specialty Outpatient Clinics, Nec in Jacksonville, FL and active since 2000.
Shahriar A Nabizadeh Md was established in 2000, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Specialty Outpatient Clinics, Nec business, which does work in the B2C market, and is classified as a Specialty Outpatient Clinics, Nec, under code number 621498 by the NAICS.
If you are seeking more information, feel free to contact Shariar A Nabizadeh at the company’s single location by writing to 11512 Lake Mead Avenue # 601, Jacksonville, Florida FL 32256 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Shahriar A Nabizadeh Md |
| Contact Person: | Shariar A Nabizadeh |
| Address: | 11512 Lake Mead Avenue # 601, Jacksonville, Florida 32256 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Specialty Outpatient Clinics, Nec |
| SIC Code: | 8093 |
| NAICS Code: | 621498 |
| Share This Business: |
Shahriar A Nabizadeh Md was started in 2000 to provide professional Specialty Outpatient Clinics, Nec under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Shariar A Nabizadeh for inquiries that concern Shahriar A Nabizadeh Md by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Shahriar A Nabizadeh Md can be found at the coordinates as well as the street address 11512 Lake Mead Avenue # 601 in Jacksonville, Florida 32256.
For its online presence, you may visit Shahriar A Nabizadeh Md’s website at and engage with its social media outlets through on Twitter and on Facebook.